Science Hub is Novo Nordisk’s one-stop portal for all our scientific publications and clinical trials, congress materials and medical updates. Sign up to gain full access.
Effects of once-weekly semaglutide treatment on HbA1c and body weight in people with recently diagnosed type 2 diabetes: a non-interventional, comparative effectiveness study
Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.